K-Retard, Potassium chloride extended-release tablets is an electrolyte replenisher.
Formula
Each capsule contains: 500 mg (in the form of extended-release microgranules) potassium chloride (= 6.6 m EqK +).
Therapeutic Action
K-Retard is indicated in patients with hypokalemia, with or without metabolic alkalosis; digitalis intoxication; patients with hypokalemic familial periodic paralysis; and for the prevention of hypokalemia in patients at particular risk if hypokalemia would develop, e.g., digitalized patients or patients with significant cardiac arrhythmias.
How Supplied
30 capsules.
Medical Specialties
Active Ingredients